Skip to content

Lumbar Puncture in Emergency Under Nitrous OXide

Impact of 50% Nitrous Oxide Inhalation on Pain Induced by Lumbar Puncture in Emergency: a Double-blind Randomized Controlled Trial.

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03941990
Acronym
LENOX
Enrollment
88
Registered
2019-05-08
Start date
2019-11-27
Completion date
2020-09-30
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Pain

Keywords

Spinal puncture, Nitrous oxide, Pain, Anxiety, Emergency

Brief summary

Lumbar puncture (LP) is a frequent exam that can cause pain and anxiety. In a scheduled setting, it has been shown that nitrous oxide use during the procedure was able to reduce both pain and anxiety. The goal of this trial is to confirm these results in a more heterogeneous group of patients having a LP, in an emergency setting.

Detailed description

Nitrous oxide (N2O) has analgesic and anxiolytic properties that are known for more than a century. Nonetheless, it's use during lumbar puncture in adults has only been investigated in a scheduled setting.Thus, this study is designed to evaluate the analgesic effect of N2O on the pain induced during lumbar puncture. Patients with urgent lumbar puncture realized for diagnosis purposes will be randomized in 2 groups. One group will inhale N2O for the 5 minutes before the puncture and during the rest of the procedure. The second group will inhale compressed air during the same period. Neither the investigator realizing the lumbar puncture, nor the patient will know which type of gaz they are inhaling (double-blinding). The maximal pain level that occurred during the procedure will be evaluated on a Numerical Rating Scale (NRS). NRS will also be used to evaluate the maximal anxiety induced by the procedure.

Interventions

Gaz inhalation will start 5 minutes before the puncture and will be continued until the end of the procedure.

OTHERPlacebo

inhale medical air (22% O2 - 78% N2)

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
Université d'Auvergne
CollaboratorOTHER
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

double blinding, gas bottles are in undistinguishable boxes, and each gas mask will be filled with odorous ink masking the sweet flavour of N2O. Neither the patient nor the person doing the LP and/or the evaluation of pain and anxiety will know the treatment used

Intervention model description

1:1 randomization to receive experimental treatment (50% N2O - 50% O2) or placebo (Medical Air: 22% O2 - 78% N2).

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients coming in emergency service who need a lumbar puncture in emergency for a diagnostic purpose * at least 18 * affiliated to the French state healthcare insurance system * able to give consent to participation

Exclusion criteria

* Previous use of nitrous oxide (medical or recreational) * Contra-indication to nitrous oxide use * Face mask phobia * Stage II obesity (BMI \> 35) * Hemodynamic instability and/or any case when coagulation results cannot be waited * Cognitive condition defined by a previous Mini Mental State Examination \< 24/30 * Confusion or any consciousness disorder that might interfere with judgment or consent * Patient unable to communicate verbally * Patient placed under a legal protection measure (tutorship, curatorship or a mandate) * Any medical condition that might contra-indicate medical research, in physician's opinion

Design outcomes

Primary

MeasureTime frameDescription
Maximal pain perceived during the lumbar puncture evaluated using a simple numeric 0-10 pain scale2-3 minutes after the end of gas inhalationMaximal level of pain during lumbar puncture. The patient will be asked to circle the digit that best describes the maximal level of pain felt during the procedure. If the patient is too painful and/or is incapacitated, the collection notebook will be fulfilled by the care provider after asking the following question: On a scale of 0 to 10, 0 being the absence of pain and 10 the maximal pain you can imagine, what is the digit best describing the maximal pain you felt during the procedure?

Secondary

MeasureTime frameDescription
Side effectsFrom the beginning of gas inhalation to a minimum of 2 hours laterEvery side effect reported by the patients attributable to gas inhalation during the procedure up to emergency service discharge. Presence, intensity and reversibility will be recorded
Spinal puncture duration2-3 minutes after the end of lumbar punctureComparison of LP duration between both groups measured in minutes (from the beginning of gas inhalation to needle removal).
Number of attempts before successful LP2-3 minutes after the end of lumbar punctureComparison of number of attempts needed to get spinal fluid, defined as number of needle removals for a single exam.
Maximal anxiety perceived during lumbar puncture evaluated using a simple numeric 0-10 scale2-3 minutes after the end of gas inhalationProportion of patients with significant anxiety
Blinding quality2-3 minutes after the end of gas inhalationAssessment of blinding in clinical trials (according to Bang et al. 2004)
Induced costthrough study completion, an average 4 monthssupplementary cost induced by the use of nitrous oxide inhalation for a total of 88 patients throughout the study (gas and consumables such as masks and pipes)
Patient Satisfaction2-3 minutes after the end of gas inhalationoverall satisfaction based on a 0-10 score and proportion of patients that would accept another lumbar puncture in the same conditions

Countries

France

Contacts

Primary ContactLise LACLAUTRE, Dr
promo_interne_drci@chu-clermontferrand.fr(0)473754963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026